Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Iqvia to $270 from $230 and keeps an Outperform rating on the shares. The firm sees potential upside to its 2025 R&DS revenue estimate and also sees margin improving in the second half given some revenue leverage as well as the impact of cost cutting programs, the analyst tells investors in a post-earnings note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV: